MX2019013120A - Composicion que contiene dioxido de cloro y metodos para su uso. - Google Patents

Composicion que contiene dioxido de cloro y metodos para su uso.

Info

Publication number
MX2019013120A
MX2019013120A MX2019013120A MX2019013120A MX2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A
Authority
MX
Mexico
Prior art keywords
chlorine dioxide
methods
same
composition containing
containing chlorine
Prior art date
Application number
MX2019013120A
Other languages
English (en)
Inventor
Gregory J Pamel
Original Assignee
Gregory J Pamel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gregory J Pamel filed Critical Gregory J Pamel
Publication of MX2019013120A publication Critical patent/MX2019013120A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Dispersion Chemistry (AREA)

Abstract

La presente invención se refiere a una composición que comprende dióxido de cloro útil para el tratamiento de infecciones activas del ojo, así como a la profilaxis y el tratamiento de tales infecciones. La invención también se refiere a los usos de composiciones que incluyen cantidades efectivas de dióxido de cloro en el ojo para obtener un beneficio sin afectar negativamente al ojo.
MX2019013120A 2017-05-05 2018-05-07 Composicion que contiene dioxido de cloro y metodos para su uso. MX2019013120A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762502085P 2017-05-05 2017-05-05
US201762608889P 2017-12-21 2017-12-21
PCT/US2018/031318 WO2018204905A1 (en) 2017-05-05 2018-05-07 Composition containing chlorine dioxide and methods for using same

Publications (1)

Publication Number Publication Date
MX2019013120A true MX2019013120A (es) 2020-07-28

Family

ID=64014393

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2023002113A MX2023002113A (es) 2017-05-05 2018-05-07 Composicion que contiene dioxido de cloro y metodos para su uso.
MX2019013120A MX2019013120A (es) 2017-05-05 2018-05-07 Composicion que contiene dioxido de cloro y metodos para su uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2023002113A MX2023002113A (es) 2017-05-05 2018-05-07 Composicion que contiene dioxido de cloro y metodos para su uso.

Country Status (5)

Country Link
US (2) US10925894B2 (es)
EP (1) EP3618613A4 (es)
CA (1) CA3062420A1 (es)
MX (2) MX2023002113A (es)
WO (1) WO2018204905A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11944097B2 (en) 2019-07-01 2024-04-02 Aseptic Health, LLC Antimicrobial composition
US20210145861A1 (en) * 2019-11-18 2021-05-20 Gregory J. PAMEL Chitosan containing compositions and methods relating to same
CN112841215B (zh) * 2020-12-30 2022-02-25 唐山市紫淳科技有限公司 一种固载二氧化氯空气消毒颗粒及其制备方法和应用
EP4056038A1 (en) * 2021-03-10 2022-09-14 Basf Se Microparticles containing active substances

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278447A (en) 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
US4177268A (en) 1973-05-30 1979-12-04 Jouveinal S.A. Method of alleviating inflammation by administration of dexamethasone derivatives
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
AU2825795A (en) * 1994-06-23 1996-01-19 Allergan, Inc. Contact lens cleaning compositions with solubilized polymers
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
US8273366B2 (en) * 2002-06-05 2012-09-25 University Of Florida Research Foundation, Incorporated Ophthalmic drug delivery system
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7157412B2 (en) * 2004-04-07 2007-01-02 Advanced Medical Optics, Inc. Alkylamine as an antimicrobial agent in ophthalmic compositions
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
CN1820607A (zh) 2006-03-31 2006-08-23 东华大学 一种二氧化氯缓释微胶囊的制备方法
US20080020064A1 (en) * 2006-07-21 2008-01-24 Advanced Vision Research Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
US8311625B2 (en) * 2009-02-04 2012-11-13 Basf Corporation Chlorine dioxide treatment for biological tissue
US20130251783A1 (en) * 2011-09-14 2013-09-26 Universitat Heidelberg Liposomes containing permeation enhancers for oral drug delivery
CN102429862B (zh) 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
EP2844295A1 (en) * 2012-05-03 2015-03-11 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
KR20170012094A (ko) * 2015-07-21 2017-02-02 주식회사 바이오건강생활 이산화염소 제어 방출용 나노입자 제조방법 및 그 용도

Also Published As

Publication number Publication date
WO2018204905A1 (en) 2018-11-08
US10925894B2 (en) 2021-02-23
EP3618613A1 (en) 2020-03-11
MX2023002113A (es) 2023-03-15
CA3062420A1 (en) 2018-11-08
EP3618613A4 (en) 2021-01-20
US20210177890A1 (en) 2021-06-17
US20180318339A1 (en) 2018-11-08

Similar Documents

Publication Publication Date Title
PH12019500932A1 (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
MX2018000351A (es) Composición para el cuidado de telas que comprende poliolésteres insaturados metatesizados.
MX2019001096A (es) Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos.
MX2019013120A (es) Composicion que contiene dioxido de cloro y metodos para su uso.
AU2016278853A8 (en) Petrolatum-based compositions comprising cationic biocides
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
CR20210108A (es) Benzamidas sustituidas con 1, 3-tiazol-2-ilo
MX2017011711A (es) Mejora en o con relacion a compuestos organicos.
EP4248968A3 (en) Tlr7/8 antagonists and uses thereof
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
PH12020500134A1 (en) Dihydrooxadiazinones
PH12017501133A1 (en) Pyrazolopyridinamines
PH12018501575A1 (en) Indolinones compounds and their use in the treatment of fibrotic diseases
MX2020001885A (es) Formulaciones de daptomicina.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX2017016231A (es) Compuestos de aminobencisoxazol como agonistas de receptores a7-nicotínicos de acetilcolina.
EA201992509A1 (ru) Гетероарилфениламинохинолины и аналоги
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
NZ764310A (en) Antibacterial compounds
MX2021015544A (es) Formulaciones de oxido de polialquileno-asparaginasa y metodos de preparacion y uso del mismo.
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2019011908A (es) Macrociclos de peptidos anti-bacterianos y uso de los mismos.
PH12018500358A1 (en) Compounds for use in an antibacterial applications
PH12019502083A1 (en) Preparation containing at least fludioxonil and a mixture containing aureobasidium pullulans strains
MX2018011095A (es) Compuestos de carbapenem.